{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:44:37Z","timestamp":1761561877546,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.cardfail.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T12:38:10Z","timestamp":1403095090000},"page":"577-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incremental Utility of Iodine-123 Meta-Iodobenzylguanidine Imaging Beyond Established Heart Failure Risk Models"],"prefix":"10.1016","volume":"20","author":[{"given":"Kaushik K.","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Hauptman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold F.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Stolker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2014.06.001_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cardfail.2006.03.003","article-title":"A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure","volume":"12","author":"Gohler","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.06.001_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/eurjhf\/hfq056","article-title":"Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis","volume":"12","author":"Davies","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2014.06.001_bib4","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJM199811193392107","article-title":"Implantable left ventricular assist devices","volume":"339","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.06.001_bib5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.06.001_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.06.001_bib7","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.290.19.2581","article-title":"Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model","volume":"290","author":"Lee","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2014.06.001_bib8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.06.001_bib9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/eurheartj\/ehm192","article-title":"Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial","volume":"28","author":"Richardson","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2014.06.001_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.hrthm.2011.08.031","article-title":"Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators","volume":"9","author":"Kramer","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2014.06.001_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.330.7492.625","article-title":"How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review","volume":"330","author":"Doust","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2014.06.001_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/HYPERTENSIONAHA.111.198028","article-title":"Left ventricular global function index by magnetic resonance imaging\u2013a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the Multi-Ethnic Study of Atherosclerosis","volume":"61","author":"Mewton","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2014.06.001_bib14","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (Adreview Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12350-012-9603-0","article-title":"Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging","volume":"19","author":"Ketchum","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12350-008-9008-2","article-title":"123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials","volume":"16","author":"Jacobson","year":"2009","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.cardfail.2014.06.001_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.CIR.0000078080.37974.D2","article-title":"Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy","volume":"108","author":"Morrow","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.06.001_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pcad.2011.03.003","article-title":"Establishing prognosis in heart failure: a multimarker approach","volume":"54","author":"Ketchum","year":"2011","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2014.06.001_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.healun.2012.04.006","article-title":"Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population","volume":"31","author":"Levy","year":"2012","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.cardfail.2014.06.001_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure","volume":"4","author":"Ky","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2014.06.001_bib22","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","article-title":"Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure","volume":"38","author":"Koglin","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.amjcard.2010.12.019","article-title":"Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure","volume":"107","author":"Kuramoto","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","article-title":"Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review","volume":"29","author":"Verberne","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2014.06.001_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0735-1097(94)00353-R","article-title":"Evidence for reduction of norepinephrine uptake sites in the failing human heart","volume":"25","author":"Bohm","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.06.001_bib27","first-page":"1757","article-title":"Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death","volume":"42","author":"Wakabayashi","year":"2001","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cardfail.2014.06.001_bib28","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1053\/euhj.2000.2407","article-title":"Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure","volume":"22","author":"Brunner-La Rocca","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2014.06.001_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jacc.2008.08.077","article-title":"The ABCD (Alternans Before Cardioverter Defibrillator) trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention","volume":"53","author":"Costantini","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2014.06.001_bib30","first-page":"e584","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults","volume":"122","author":"Greenland","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2014.06.001_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641400219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641400219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:41:30Z","timestamp":1761028890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191641400219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S107191641400219X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.06.001","relation":{},"ISSN":["1071-9164"],"issn-type":[{"type":"print","value":"1071-9164"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incremental Utility of Iodine-123 Meta-Iodobenzylguanidine Imaging Beyond Established Heart Failure Risk Models","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}